The surgical management of BPH has transformed in the past decade. TURP — the gold standard since the 1970s — remains effective but carries significant sexual side effects and recovery time. Newer procedures (UroLift, Rezūm) achieve comparable symptom improvement through less invasive mechanisms, with faster recovery and better preservation of sexual function. Understanding the differences is essential for informed decision-making.
Is Newer Automatically Better Here? Short Answer
Not automatically — this is one of the more nuanced procedural decisions in urology precisely because the newer, less invasive options (UroLift, Rezūm) trade some symptom-relief magnitude and long-term durability for meaningfully better sexual function preservation and faster recovery, rather than being a strict upgrade over TURP in every dimension. TURP still produces the largest and most durable IPSS improvement of any option and remains the right choice for men with very large prostates, a history of urinary retention, or significant obstruction where the newer minimally invasive procedures simply aren't as effective. UroLift and Rezūm are better understood as a different point on the effectiveness-versus-invasiveness spectrum, appropriate for men whose BPH is significant enough to warrant a procedure but who prioritize preserving ejaculatory function and want a faster recovery, and who are willing to accept a somewhat lower ceiling on symptom improvement and a higher chance of eventually needing retreatment. The right choice genuinely depends on prostate anatomy (size, whether there's a median lobe), symptom severity, and how heavily a man weighs sexual function preservation against maximum symptom relief.
When BPH Requires More Than Medication
- •Medication failure: persistent IPSS ≥15 despite 6+ months of optimal medical therapy
- •Medication intolerance: side effects that affect quality of life
- •Acute urinary retention history
- •Elevated post-void residual (>300ml) indicating significant obstruction
- •Recurrent urinary tract infections from BPH
- •Bladder stones secondary to BPH obstruction
- •Patient preference to avoid long-term medication
TURP: The Gold Standard (With Its Downsides)
Transurethral resection of the prostate removes prostate tissue using an electrical loop through a scope inserted via the urethra. It produces the largest, most durable IPSS improvement of any BPH procedure (~15 points). However: retrograde ejaculation in most men (usually permanent), general or spinal anesthesia required, a short hospital stay, a recovery of several weeks, and a risk of ED. Best for large prostates (>80cc), retention history, or when other procedures have failed.
UroLift: Quick Recovery, No Sexual Side Effects
The Prostatic Urethral Lift (UroLift) places small permanent implants that mechanically retract obstructing prostate tissue, widening the urethral channel without cutting, heating, or removing tissue [1]. IPSS improvement: approximately 11 points at 12 months (LIFT trial) [1]. Ejaculatory function is preserved in the great majority of men. Office procedure under local anesthesia. Return to normal activity in 1–3 days. Key limitation: not suitable for men with median lobe enlargement (a specific prostate anatomy variant).
Rezūm (Water Vapor Therapy): What It Is and Who It's For
Rezūm uses radiofrequency-generated water vapor (steam) delivered directly into hyperplastic prostate tissue via a transurethral needle [2]. The steam condenses within the tissue, releasing energy that destroys excess cells. The body then reabsorbs the treated tissue over 3 months. IPSS improvement: approximately 12 points at 12 months. Ejaculatory function preserved in most men. Office/clinic procedure. Symptom improvement continues building for 3 months post-procedure. Can treat median lobe (unlike UroLift).
Comparing Results: IPSS Improvement Across Procedures
- •TURP: ~15 points IPSS improvement (highest), most durable long-term
- •Rezūm: ~12 points IPSS improvement, 5-year data shows sustained results
- •UroLift: ~11 points IPSS improvement, some patients require retreatment at 5 years
- •Alpha blockers (medication): smaller improvement — procedures generally outperform
Which Procedure Preserves Sexual Function Best?
- •UroLift: best sexual function preservation — ejaculatory function preserved in the great majority of men, minimal ED risk
- •Rezūm: good preservation — most men preserve ejaculatory function, though some experience retrograde ejaculation
- •TURP: highest risk — retrograde ejaculation in most men (usually permanent), with some risk of ED
What the Recovery Experience Actually Looks Like
Beyond the headline recovery-time numbers, it's worth understanding what each recovery period actually involves day to day. TURP recovery includes a hospital stay, a catheter for several days, and a genuine 4-6 week window of restricted activity, heavier post-procedure discomfort, and often noticeable blood in the urine for the first couple weeks — a meaningfully bigger disruption to daily life than the office-based alternatives. UroLift recovery is markedly different: most men go home the same day, catheter use is uncommon or brief, and while some urinary urgency, burning, and blood in urine is expected for the first few weeks, most men return to normal non-strenuous activity within just a few days. Rezūm recovery sits between the two in some respects — an office procedure with relatively quick initial recovery, but because the treated tissue is gradually reabsorbed by the body over roughly 3 months, some men experience a temporary worsening of urinary symptoms in the first few weeks post-procedure before the treatment effect fully develops, which is worth knowing in advance so it isn't mistaken for the procedure not working.
ManCore's free daily symptom log tracks urinary frequency, stream quality, urgency, and nocturia — the same four domains used in the IPSS questionnaire — so you can see your BPH symptoms trend over time.
Track Your IPSS Score — Free
Stop guessing whether your symptoms are improving month to month. ManCore's free symptom diary logs your urinary frequency, stream quality, urgency, and nocturia daily — and shows you a visual timeline so you can see exactly where you stand.
Supplements for BPH Symptom Support
Super Beta Prostate Supplement
Combines pumpkin seed oil with beta-sitosterol, selenium, and zinc for daily BPH symptom support.
NOW Foods Pumpkin Seed Oil
Standardized cold-pressed pumpkin seed oil capsules, commonly used to support urinary flow.
Affiliate disclosure: ManCore earns a small commission on purchases made through these links at no extra cost to you.
Frequently Asked Questions
Is UroLift better than TURP?
Depends on priorities. UroLift: faster recovery, preserves ejaculation, office procedure. TURP: larger IPSS improvement, more durable long-term, handles larger prostates. For men who want to preserve sexual function and have prostates under 80cc without median lobe, UroLift is often preferred.
BPH surgery options?
Main options: UroLift (office, sexual function preserved), Rezūm (office, tissue ablation), TURP (OR, most effective), HoLEP (laser, for large prostates), laser vaporization (PVP/Greenlight). Choice depends on prostate size, anatomy, sexual function priorities, and available expertise.
UroLift side effects?
Most common: temporary hematuria (blood in urine), dysuria (painful urination), urgency, and frequency in the first weeks. These resolve spontaneously. Serious complications are rare. Unlike TURP, retrograde ejaculation is essentially absent.
Can these procedures be repeated if symptoms return years later?
Yes — UroLift and Rezūm both can be retreated if symptoms recur or the prostate continues to grow after the initial procedure, and retreatment rates at 5 years are a known, documented part of their long-term outcome data. TURP is also technically repeatable, though a second TURP is less commonly needed given its more durable initial result and is a more involved procedure to repeat than the minimally invasive options.
How does a urologist decide which procedure is right for a specific patient?
The decision integrates several factors: prostate size and shape (particularly whether a median lobe is present, which rules out UroLift), symptom severity and IPSS score, how much the patient prioritizes preserving ejaculatory function versus maximizing symptom relief, and the patient's overall health and anesthesia tolerance, since TURP requires general or spinal anesthesia while the office-based options use only local anesthesia. A thorough pre-procedure evaluation, typically including a transrectal ultrasound to assess prostate anatomy, is standard before recommending a specific approach.
Are there other minimally invasive options beyond UroLift and Rezūm worth knowing about?
Yes — HoLEP (holmium laser enucleation) and laser vaporization (PVP/Greenlight) are additional options, generally reserved for larger prostates where they can achieve TURP-level symptom improvement with somewhat better safety and recovery profiles than traditional TURP, though they still require general or spinal anesthesia unlike UroLift or Rezūm. Availability varies by region and depends on whether local urologists have specific training and equipment for these more specialized laser techniques.
How soon after any of these procedures can normal sexual activity resume?
For UroLift and Rezūm, most urologists clear resumption of sexual activity within roughly 1-2 weeks once initial healing and any catheter use has resolved, though individual guidance varies. TURP typically requires a longer wait, often 4-6 weeks, given the more invasive nature of the procedure and longer overall recovery window — following your specific surgeon's guidance rather than a generic timeline is always the right approach.
Does insurance typically cover these procedures?
TURP is a long-established, well-covered procedure across most insurance plans given its decades-long track record. UroLift and Rezūm have gained broader coverage over recent years as their outcome data has matured, though coverage details, prior authorization requirements, and any out-of-pocket cost can vary by specific plan — checking directly with the insurer before proceeding is worthwhile for either newer option.
What happens if a minimally invasive procedure doesn't provide enough relief?
If UroLift or Rezūm doesn't produce adequate symptom improvement, or if relief fades over time, the options remain open — repeating the same procedure, trying the other minimally invasive option, adding or resuming medication, or escalating to TURP or a laser-based procedure are all reasonable next steps depending on the specific situation, since none of these choices close off future options.
Do any of these procedures affect future prostate cancer screening or treatment options?
None of these BPH procedures interfere with PSA testing accuracy or future prostate cancer detection in a lasting way, though a temporary PSA elevation can occur shortly after any prostate manipulation, so timing PSA tests appropriately after a procedure is a reasonable practical consideration to discuss with your urologist.
Is anesthesia risk a major factor in choosing between these options?
For men with significant cardiac or pulmonary risk factors that make general or spinal anesthesia riskier, this can meaningfully favor UroLift or Rezūm, both performed under local anesthesia only, over TURP — a consideration worth raising explicitly during the pre-procedure evaluation if anesthesia risk is a concern.